These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Diagnostic importance of digital topographic assessment of Raynaud's phenomenon. A prospective study of a population of 522 patients]. Pistorius MA; Planchon B J Mal Vasc; 1995; 20(1):14-20. PubMed ID: 7745354 [TBL] [Abstract][Full Text] [Related]
23. [Pathogenesis of Raynaud's phenomenon, disease and syndrome]. Bartolo M; Antignami PL; Cestari M; Rufini E Angiologia; 1985; 37(4):161-70. PubMed ID: 4025912 [No Abstract] [Full Text] [Related]
24. Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients. Planchon B; Pistorius MA; Beurrier P; De Faucal P Angiology; 1994 Aug; 45(8):677-86. PubMed ID: 8048777 [TBL] [Abstract][Full Text] [Related]
25. Raynaud's phenomenon: pathogenesis and management. Bakst R; Merola JF; Franks AG; Sanchez M J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283 [TBL] [Abstract][Full Text] [Related]
30. Image analysis of nail fold capillaries in patients with Raynaud's phenomenon. Ohtsuka T; Yamakage A; Tamura T Cutis; 1995 Oct; 56(4):215-8. PubMed ID: 8575220 [TBL] [Abstract][Full Text] [Related]
31. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma. Colakoğlu M; Cobankara V; Akpolat T Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574 [TBL] [Abstract][Full Text] [Related]
33. Raynaud's phenomenon and digital necrosis induced by interferon-alpha. Bachmeyer C; Farge D; Gluckman E; Miclea JM; Aractingi S Br J Dermatol; 1996 Sep; 135(3):481-3. PubMed ID: 8949451 [TBL] [Abstract][Full Text] [Related]
34. [The role of sympathetic reactivity in the development of Raynaud's syndrome]. Shcherbakov AB; Guseva NG; Mach ZS Ter Arkh; 1993; 65(5):22-5. PubMed ID: 8036589 [TBL] [Abstract][Full Text] [Related]
36. [Validity of plethysmography and the digital temperature recovery test in the diagnosis of primary and occupational Raynaud's phenomenon]. Laroche GP; Thériault G Clin Invest Med; 1987 Mar; 10(2):96-102. PubMed ID: 3581549 [TBL] [Abstract][Full Text] [Related]
39. A suspicious reason for Raynaud's phenomenon: Intrauterine device. Diken AI; Yalçınkaya A; Aksoy E; Yılmaz S; Çağlı K Vascular; 2015 Jun; 23(3):327-8. PubMed ID: 25348785 [TBL] [Abstract][Full Text] [Related]
40. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis]. Serri J; Legré R; Veit V; Guardia C; Gay AM Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]